Float Short %

21.18

Margin Of Safety %

Put/Call OI Ratio

0.36

EPS Next Q Diff

0.28

EPS Last/This Y

4.57

EPS This/Next Y

4.02

Price

39.4

Target Price

111.92

Analyst Recom

1.08

Performance Q

-18.91

Upside

-263.6%

Beta

-3.16

Ticker: SLNO

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	SLNO	42.36	0.32	0.07	30091
2026-01-26	SLNO	42.86	0.31	0.04	30747
2026-01-27	SLNO	43.21	0.31	0.20	31075
2026-01-28	SLNO	41.6	0.32	2.63	30923
2026-01-29	SLNO	40.52	0.33	0.54	31098
2026-01-30	SLNO	38.59	0.33	0.04	29932
2026-02-02	SLNO	42.31	0.36	0.44	28926
2026-02-03	SLNO	44.02	0.38	0.01	29888
2026-02-04	SLNO	42.15	0.36	1.22	30832
2026-02-05	SLNO	39.55	0.37	0.06	31286
2026-02-06	SLNO	41.6	0.37	1.18	31662
2026-02-09	SLNO	40.87	0.37	0.33	31863
2026-02-10	SLNO	40.48	0.37	0.20	31902
2026-02-11	SLNO	40.02	0.38	308.54	32147
2026-02-12	SLNO	38.67	0.40	0.05	32643
2026-02-13	SLNO	37.23	0.39	0.04	33037
2026-02-17	SLNO	38.5	0.39	0.06	33248
2026-02-18	SLNO	38.62	0.37	3.25	33248
2026-02-20	SLNO	39.37	0.36	0.52	33008
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	SLNO	42.37	-	-	0.19
2026-01-26	SLNO	42.84	-	-	0.19
2026-01-27	SLNO	43.18	-	-	0.19
2026-01-28	SLNO	41.60	-	-	0.19
2026-01-29	SLNO	40.55	-	-	0.19
2026-01-30	SLNO	38.61	-	-	0.19
2026-02-02	SLNO	42.31	-	-	0.19
2026-02-03	SLNO	44.04	-	-	0.19
2026-02-04	SLNO	42.13	-	-	0.19
2026-02-05	SLNO	39.58	-	-	0.19
2026-02-06	SLNO	41.57	-	-	0.19
2026-02-09	SLNO	40.87	-	-	0.19
2026-02-10	SLNO	40.49	-	-	0.19
2026-02-11	SLNO	39.99	-	-	0.19
2026-02-12	SLNO	38.69	-	-	0.19
2026-02-13	SLNO	37.24	-	-	0.19
2026-02-17	SLNO	38.52	-	-	0.19
2026-02-18	SLNO	38.61	-	-	0.19
2026-02-19	SLNO	39.43	-	-	0.19
2026-02-20	SLNO	39.40	-	-	0.19
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	SLNO	0.00	20.31	22.09
2026-01-26	SLNO	0.00	19.93	22.09
2026-01-27	SLNO	0.00	19.93	22.09
2026-01-28	SLNO	0.00	19.93	23.19
2026-01-29	SLNO	0.00	19.93	23.19
2026-01-30	SLNO	0.00	19.93	23.19
2026-02-02	SLNO	0.00	21.20	23.28
2026-02-03	SLNO	0.00	21.20	23.28
2026-02-04	SLNO	0.00	21.20	23.28
2026-02-05	SLNO	0.00	21.20	23.28
2026-02-06	SLNO	0.00	21.20	23.28
2026-02-10	SLNO	0.00	18.96	23.28
2026-02-11	SLNO	0.00	18.96	21.18
2026-02-12	SLNO	0.00	18.96	21.18
2026-02-13	SLNO	0.00	18.96	21.18
2026-02-17	SLNO	0.00	20.14	21.18
2026-02-18	SLNO	0.00	20.14	21.18
2026-02-19	SLNO	0.00	20.14	21.18
2026-02-20	SLNO	0.00	20.14	21.18
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.47

Avg. EPS Est. Current Quarter

0.62

Avg. EPS Est. Next Quarter

0.75

Insider Transactions

Institutional Transactions

20.14

Beta

-3.16

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

56.4

Max Drawdown 5-Year %

-98

Target Price

111.92

P/E

Forward P/E

9.35

PEG

P/S

21.43

P/B

4.27

P/Free Cash Flow

EPS

-1.84

Average EPS Est. Cur. Y

0.19

EPS Next Y. (Est.)

4.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-79.5

Relative Volume

0.95

Return on Equity vs Sector %

-44.9

Return on Equity vs Industry %

-27.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

Soleno Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 152

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

stock quote shares SLNO – Soleno Therapeutics Inc Stock Price stock today

news today SLNO – Soleno Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SLNO – Soleno Therapeutics Inc yahoo finance google finance

stock history SLNO – Soleno Therapeutics Inc invest stock market

stock prices SLNO premarket after hours

ticker SLNO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SLNO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y